A leading center for Sickle Cell management and research in Africa, providing comprehensive care since 1992.
The KCSCD envisions Newborn babies with SCD enrolled into care by two to three months of age and started on penicillin prophylaxis, folic acid supplementation, comprehensive care in their lifespan.
Comprehensive specialized care for patients in their lifespan.
Envision clinic enrolment within 2-3 months.
"Our vision is to provide equitable care and enhance the quality of life for individuals affected by Sickle Cell Disease (SCD). We strive to be a leading center for SCD management in Africa through comprehensive screening programs, cutting edge treatments, and collaborative partnerships. We are dedicated to improving patient outcomes."
Newborn screening to identify SCD early for timely intervention and improved outcomes.
Holistic care encompassing medication, education, and regular checkups for effective SCD management.
Working with government and Novartis AG to provide free Hydroxyurea therapy to patients.
Your contributions help us provide life-saving treatments, research, and comprehensive care for patients across Ghana.
Join our dedicated team of professionals and advocates in creating a positive impact for the sickle cell community.